Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
PUT
Forestar Group
FOR
$1.46B
| $1.36M | ﹤0.01% |
116,600
+104,300
| +848% | +$1.26M |
|
4202
PUT
Repligen
RGEN
$9.95B
| $1.36M | ﹤0.01% |
45,200
+900
| +2% | +$27.2K |
|
4203
CALL
ResMed
RMD
$34.7B
| $1.36M | ﹤0.01% |
21,000
+8,700
| +71% | +$579K |
|
|
ITG
4204
CALL
DELISTED
Investment Technology Group Inc
ITG
| $1.36M | ﹤0.01% |
79,400
+62,900
| +381% | +$1.04M |
|
|
HIBB
4205
CALL
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.36M | ﹤0.01% |
34,100
+2,100
| +7% | +$79K |
|
|
CEB
4206
DELISTED
CEB Inc.
CEB
| $1.36M | ﹤0.01% |
24,960
-15,852
| -39% | -$948K |
|
4207
CALL
Greif
GEF
$4.78B
| $1.36M | ﹤0.01% |
+27,400
| New | +$1.17M |
|
|
NPTN
4208
CALL
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.36M | ﹤0.01% |
83,200
+22,900
| +38% | +$322K |
|
|
VPU
4209
PUT
Vanguard Utilities ETF
VPU
$8.26B
| $1.36M | ﹤0.01% |
12,700
+1,100
| +9% | +$122K |
|
|
MEET
4210
CALL
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.36M | ﹤0.01% |
218,900
+168,800
| +337% | +$1.03M |
|
4211
PUT
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $1.36M | ﹤0.01% |
13,600
+10,600
| +353% | +$1.04M |
|
|
ALDW
4212
DELISTED
Alon USA Partners LP
ALDW
| $1.36M | ﹤0.01% |
+157,837
| New | +$1.55M |
|
|
RICE
4213
CALL
DELISTED
Rice Energy Inc.
RICE
| $1.35M | ﹤0.01% |
51,900
-338,400
| -87% | -$8.4M |
|
4214
Invesco Semiconductors ETF
PSI
$2.35B
| $1.35M | ﹤0.01% |
123,777
+48,768
| +65% | +$491K |
|
4215
CALL
Saic
SAIC
$5.33B
| $1.35M | ﹤0.01% |
19,500
-14,600
| -43% | -$922K |
|
4216
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$110M
| $1.35M | ﹤0.01% |
+63,369
| New | +$1.34M |
|
4217
Selective Insurance
SIGI
$5.51B
| $1.35M | ﹤0.01% |
33,919
| – | – |
|
4218
CALL
Unum
UNM
$14.7B
| $1.35M | ﹤0.01% |
38,300
-17,400
| -31% | -$589K |
|
|
WCN
4219
Waste Connections
WCN
$41.7B
| $1.35M | ﹤0.01% |
27,150
| – | – |
|
4220
CALL
Universal Corp
UVV
$1.14B
| $1.35M | ﹤0.01% |
23,200
+8,600
| +59% | +$507K |
|
|
VIVO
4221
PUT
DELISTED
Meridian Bioscience Inc
VIVO
| $1.35M | ﹤0.01% |
70,000
+13,800
| +25% | +$270K |
|
4222
CALL
FreightCar America
RAIL
$235M
| $1.35M | ﹤0.01% |
93,800
+17,800
| +23% | +$254K |
|
4223
PUT
Bloomin' Brands
BLMN
$906M
| $1.35M | ﹤0.01% |
78,200
+51,700
| +195% | +$959K |
|
|
AKS
4224
DELISTED
AK Steel Holding Corp
AKS
| $1.35M | ﹤0.01% |
278,831
+175,474
| +170% | +$891K |
|
|
ELNK
4225
DELISTED
EarthLink Holdings Corp.
ELNK
| $1.35M | ﹤0.01% |
217,226
+138,300
| +175% | +$895K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.